Cerus Corporation logo

Cerus Corporation

NASDAQ:CERS

Overview | Financials
Company Name Cerus Corporation
Symbol CERS
Currency USD
Price 2.02
Market Cap 374,299,940
Dividend Yield 0%
52-week-range 1.21 - 2.59
Industry Medical Devices
Sector Healthcare
CEO Mr. William M. Greenman
Website https://www.cerus.com

An error occurred while fetching data.

About Cerus Corporation

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company

Related Stocks

Treace Medical Concepts, Inc. logo

Treace Medical Concepts, Inc.

TMCI

5.33 USD

Procaps Group S.A. logo

Procaps Group S.A.

PROC

1.94 USD

OrthoPediatrics Corp. logo

OrthoPediatrics Corp.

KIDS

30.66 USD

Morphic Holding, Inc. logo

Morphic Holding, Inc.

MORF

56.99 USD

National Research Corporation logo

National Research Corporation

NRC

21.71 USD

REGENXBIO Inc. logo

REGENXBIO Inc.

RGNX

11.48 USD

Keros Therapeutics, Inc. logo

Keros Therapeutics, Inc.

KROS

52.51 USD

Syndax Pharmaceuticals, Inc. logo

Syndax Pharmaceuticals, Inc.

SNDX

19.1 USD

Sharecare, Inc. logo

Sharecare, Inc.

SHCR

1.4 USD

Financials

Numbers are in millions USD

Numbers are in millions USD